 |
|

|
 |
|
2013 Genitourinary Cancers Symposium
Orlando, Florida
February 14-16 |
Including a renal cancer session on clinical decision-making and the evaluation of risk; discussions on imaging, pathology, radiology and molecular diagnostics; translational research-themed General Sessions; Best of Journals Sessions on prostate cancer and renal cancer; and interactive sessions featuring Audience Response technology (ARS) and eQ&A.
Contact: Tel: 703-449-6418; Fax: 703-563-2715; Email: guregistration@jspargo.com;
Website: http://gucasym.org/
|
|
|
8th International Breast Cancer Congress
Tehran, Iran
February 20-22
|
Translational research, new agents, molecular and functional diagnostics, biomarkers and cutting-edge research applications in the clinical setting.
Contact: Fatemeh Keshmir, Executive Manager, Cancer research centre, Shahid Beheshti University of Medical Sciences, Tel: 011-98-21-2274-8001-2; Fax: 011-98-21-2274-8001-2; Email: keshmirf@yahoo.com; Website: http://crc.sbmu.ac.ir/pages/view/pageid/49/lang/en |
|
|
Personalized Medicine 2013 - Signalling Pathways: Targeting the HER/EGFR Family: Focus on Breast, Lung & Colorectal Cancers
Sitges, Spain
March 1-2
|
This meeting will focus on the HER family of receptors across lung, breast and colorectal cancers. A plenary discussion on principles of signalling transduction, mechanisms of primary and secondary resistance to targeted therapy, preclinical models and biomarkers dissection. Discussion within parallel sessions on dysregulation of HER receptors and subsequent potentials for targeting by different strategies in breast, lung and colorectal cancers.
Contact: Tel: 011-41-91-973-1900; Fax: 011-41-91-973-1902; Email: esmo@esmo.org; Website: www.esmo.org/events/signaling-pathways-2013.html |
|
|
11th International Congress on Targeted Anticancer Therapies: TAT 2013
Paris, France
March 4-6
|
Focusing on promising new agents and molecular targets that are, or soon will be, in Phase 1 clinical study; clinical and translational research are discussed. Educational introductions of target biology help newcomers understand the science behind new targets.
Contact: Tel: 011-31-8-8089-8101; Fax: 011-31-8-8089-8109;
Email: tat@congressbydesign.com; Website: www.tatcongress.org/tat-2013.html |
|
|
2013 Annual Meeting on Women's Cancer
Los Angeles, California
March -12
|
Seminars and plenary sessions on breast, cervical, ovarian and endometrial cancers, and gynecologic care.
Contact: Mandy Marneris, Education & Meetings Assistant, Society of Gynecologic Oncologists; Tel: 312-235-4060 ext. 251; Email: mandy.marneris@sgo.org;
Website: www.sgomeetingsonwomenscancer.com/
|
|
|
American Association for Cancer Research Annual Meeting 2013
Washington, DC
April 6-10
|
This meeting brings together the latest findings in all major areas of cancer research: 6,162 proffered papers presented in 210 poster sessions and 30 minisymposia; 50 educational sessions and methods workshops for those seeking a foundation of knowledge in rapidly developing areas; 843 webcasts of the scientific talks available to attendees and subscribers.
Contact: Tel: 215-440-9300; Fax: 215-440-9313; Email: aacr@aacr.org; Website: www.aacr.org/home/scientists/meetings--workshops/aacr-annual-meeting-2013.aspx |
|
|
8th Annual Ontario Thoracic Cancer Conference
Niagara-on-the-Lake, Ontario
April 19-21
|
Promoting understanding of the management of thoracic malignancies for medical oncologists, radiation oncologists, radiation therapists, thoracic surgeons, respirologists, nurses, research personnel and trainees.
Contact: Natalie Park, McMaster University; Tel: 905-525-9140 ext. 22990; Fax: 905-572-7099; Email: parkna@mcmaster.ca; Website: www.fhs.mcmaster.ca/conted/calendar.html |
|
| These
listings are accurate as of publication date. Details and contact
information are provided according to availability. To post an upcoming
meeting in the next issue of Oncology Exchange, please contact: editors@oncologyex.com |